Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-30

Clinical Trial Update: Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus [NA]

View source ↗

Summary

A completed clinical trial investigating Fibroblast Growth Factors 19 and 21 in gestational diabetes mellitus has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FGF19 (FGF19)
  • FGF21 (Fibroblast Growth Factor 21)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Gestational Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2023-05-30